Clinical pharmacists on medical care of pediatric inpatients: A single-center randomized controlled trial

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Zhang, Chuan ^a   Zhang, Lingli ^a   Huang, Liang ^a   Luo, Rong ^b   Wen, Jin ^c  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

^c SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHILD; CHILD HEALTH CARE; CLINICAL EFFECTIVENESS; CLINICAL PHARMACY; CONTROLLED STUDY; DIGESTIVE SYSTEM DISEASE; DRUG COST; DRUG SURVEILLANCE PROGRAM; FEMALE; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HOSPITALIZATION COST; HOSPITALIZED CHILD; HUMAN; INFANT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; NEUROLOGIC DISEASE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PHARMACIST ATTITUDE; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; SCHOOL CHILD; ADOLESCENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; ECONOMICS; HEALTH CARE COST; HEALTH CARE DELIVERY; HOSPITAL PATIENT; HOSPITALIZATION; METHODOLOGY; NEWBORN; ORGANIZATION AND MANAGEMENT; PATIENT CARE; PEDIATRICS; PHARMACIST; PRESCHOOL CHILD; PROFESSIONAL STANDARD; STATISTICS;

ADOLESCENT; ADVERSE DRUG REACTION REPORTING SYSTEMS; CHILD; CHILD, PRESCHOOL; DELIVERY OF HEALTH CARE; FEMALE; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; INPATIENTS; LENGTH OF STAY; MALE; PATIENT CARE TEAM; PATIENT COMPLIANCE; PEDIATRICS; PHARMACISTS; PROFESSIONAL ROLE;

EID: 84856120107     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0030856     Document Type: Article

References (48)

1. Conroy S, Choonara I, Impicciatore P, Mohn A, Arnell H, et al. (2000) Survey of unlicensed and off label drug use in pediatric wards in European countries. BMJ 320: 79-82.
2. Promoting safety of medicines for children [EB/OL]. www.who.com 2010-1-20.
3. Wong ICK, Ghaleb MA, Franklin-Dean B, Barber N, (2004) Incidence and nature of dosing errors in pediatric medications. Drug Safety 27: 661-70.
4. Academic Health Centers (2003) Leading Change in the 21st Century Washington, DC National Academy Press.
5. Kohn LT, Corrigan JM, Donaldson MS, (2000) To Err Is Human Washington, DC National Academy Press.
6. Leape LL, Cullen DJ, Clapp MD, Burdick E, Demonaco HJ, et al. (1999) Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA 282: 267-270.
7. Fortescue EB, Kaushal R, Landrigan CP, McKenna KJ, Clapp MD, et al. (2003) Prioritizing strategies for preventing medication errors and adverse drug events in paediatric inpatients. Paediatrics 111: 722-9.
8. Bailey TC, Ritchie DJ, McMullin ST, Kahn M, Reichley RM, et al. (1997) A randomized, prospective evaluation of an interventional program to discontinue intravenous antibiotics at two tertiary care teaching institutions. Pharmacotherapy 17: 277-281.
9. Gibson JT, Vance AL, Newton DS, (1975) Influence on medication therapy of increased patient services by pharmacists in a pediatric hospital. Am J Hosp Pharm 35: 495-500.
10. Lal LS, Anassi EO, McCants ED, (1995) Documentation of the first steps of paediatric pharmaceutical care in a county hospital. Hosp Pharm 30: 1107-8 1111-2.
11. Nazareth I, Burton A, Shulman S, Smith P, Haines A, et al. (2001) A pharmacy discharge plan for hospitalized elderly patients: a randomized controlled trial. Age Ageing 30: 33-40.
12. Devlin JW, Holbrook AM, Fuller HD, (1979) Pharmacist monitoring of parenteral nutrition: clinical and cost effectiveness. Am J Hosp Pharm 36: 785-7.
13. Dice JE, Burckart GJ, Woo JT, Helms RA, (1981) Standardized versus pharmacist-monitored individualized parenteral nutrition in low-birth-weight infants. Am J Hosp Pharm 38: 1487-1489.
14. Gibson JT, Alexander VL, Newton DS, (1975) Influence on medication therapy of increased patient services by pharmacists in a pediatric hospital. Am J Hosp Pharm 32: 495-500.
15. Sanghera N, Chan PY, Zahra F, Planner C, Lee KK, et al. (2006) Review Interventions of hospital pharmacists in improving drug therapy in children: a systematic literature review. Drug Safety 29: 1031-47.
16. Williford SL, Johnson DF, (1995) Impact of pharmacist counseling on medication knowledge and compliance. Military Medicine 160: 561-564.
17. Nikolaus T, Specht-Leible N, (2001) A pharmacy discharge plan for hospitalized elderly patients-a randomized controlled trial. Age and Ageing 30: 33-40.
18. Leape LL, Cullen DJ, Clapp MD, Burdick E, Demonaco HJ, et al. (1999) Pharmacist Participation on Physician Rounds and Adverse Drug Events in the Intensive Care Unit. JAMA 282: 267-70.
19. Krupicka MI, Bratton SL, Sonnenthal K, Goldstein B, (2002) Impact of a pediatric clinical pharmacist in the pediatric intensive care unit. Crit Care Med 30: 919-921.
20. Kucukarslan SN, Peters M, Mlynarek M, Nafziger DA, (2003) Pharmacists on Rounding Teams Reduce Preventable Adverse Drug Events in Hospital General Medicine Units. Arch Intern Med 163: 2014-2018.
21. Koren G, Reich A, Hales B, (1991) Use of clinical pharmacists to prevent medication errors in children. J Pharm Technol 7: 219-21.
22. Strong DK, Tsang WY, (1993) Focus and impact of pharmacists interventions. Can J Hosp Pharm 46: 101-8.
23. Virani A, Crown N, (2003) The impact of a clinical pharmacist on patient and economic outcomes in a child and adolescent mental health unit. Can J Hosp Pharm 56: 158-62.
24. Condren ME, Haase MR, Luedtke SA, Gaylor AS, (2004) Clinical activities of an academic paediatric pharmacy team. Ann Pharmacother 38: 574-8.
25. Guy J, Persaud J, Davies E, Harvey D, (2003) Drug errors: what role do nurses and pharmacists have in minimizing the risk? J Child Health Care 7: 277-90.
26. Folli HL, Poole RL, Benitz WE, Russo JC, (1987) Medication error prevention by clinical pharmacists in two children's hospitals. Peadiatrics 79: 718-22.
27. Impicciatore P, Choonaral I, Clarkson A, Provasi D, Pandolfini C, et al. (2001) Incidence of adverse drug reactions in paediatric in/out-patients: a systematic review and meta-analysis of prospective studies. Br J Clin Pharmacol 52: 77-83.
28. Haig GM, Kiser LA, (1991) Effect of pharmacist participation on a medical team on costs, charges, and length of stay. Am J Hosp Pharm 48: 1457-1462.
29. Boyko WL, Yurkowski PJ, Ivey MF, Armitstead JA, Roberts BL, (1997) Pharmacist influence on economic and morbidity outcomes in a tertiary care teaching hospital. Am J Health Syst Pharm 54: 1591-1595.
30. Gums JG, Yancey RW, Hamilton CA, Kubilis PS, (1999) A randomized, prospective study measuring outcomes after antibiotic therapy intervention by a multidisciplinary consult team. Pharmacotherapy 19: 1369-1377.
31. Gentry CA, Greenfield RA, Slater LN, Wack M, Huycke MM, (2000) Outcomes of an antimicrobial control program in a teaching hospital. Am J Health Syst Pharm 57: 268-274.
32. Destache CJ, Meyer SK, Padomek MT, Ortmeier BG, (1989) Impact of a clinical pharmacokinetic service on patients treated with aminoglycosides for gram negative infections. DICP 23: 33-38.
33. Smythe MA, Shah PP, Spiteri TL, Lucarotti RL, Begle RL, (1998) Pharmaceutical care in medical progressive care patients. Ann Pharmacother 32: 294-299.
34. Clapham CE, Hepler CD, Reinders TP, Lehman ME, Pesko L, (1988) Economic consequences of two drug use control systems in a teaching hospital. Am J Hosp Pharm 45: 2329-2340.
35. Kucukarslan SN, Peters M, Mlynarek M, Nafziger DA, (2003) Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units. Arch Intern Med 163: 2014-2018.
36. Bolas H, Brookes K, Scott M, McElnay J, (2004) Evaluation of a hospital-based community liaison pharmacy service in Northern Ireland. Pharm World Sci 26: 114-120.
37. Lipton HL, Bird JA, (1994) The impact of clinical pharmacists' consultations on geriatric patients' compliance and medical care use: a randomized controlled trial. Gerontologist 34: 307-315.
38. Clapham CE, Hepler CD, Reinders TP, Lehman ME, Pesko L, (1988) Economic consequences of two drug use control systems in a teaching hospital. Am J Hosp Pharm 45: 2329-2340.
39. Edwards M, Pathy MSJ, (1984) Drug counseling in the elderly and predicting compliance. Practitioner 228: 291-300.
40. Parkin DM, Henney CR, Quirk J, Crooks J, (1976) Deviation from prescribed drug treatments after discharge from hospital. Br Med J 2: 686-8.
41. Col N, Fanale JE, Kronholm P, (1990) The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med 150: 841-5.
42. Woroniecki CL, Mackercher PL, Flagler DG, Berchou R, Cook JA, (1982) Effect of pharmacist counseling on drug information recall. Am J Hosp Pharm 39: 1907-10.
43. Cole P, Emmanuel S, (1971) Drug consultation: its significance to the discharged patient and its relevance as a role for the pharmacist. Am J Hosp Pharm 28: 954-60.
44. Smith L, McGowan L, Moss-Barclay C, Wheater J, Knass D, et al. (1997) An investigation of hospital generated pharmaceutical care when patients are discharged home from hospital. Br J Clin Pharmacol 44: 163-165.
45. Lipton HL, Bird JA, (1994) The impact of clinical pharmacists' consultations on geriatric patients' compliance and medical care use: a randomized controlled trial. Gerontologist 34: 307-315.
46. Bjornson DC, Hiner WO, Potyk RP, Nelson BA, Lombardo FA, et al. (1993) Effect of pharmacists on health care outcomes in hospitalized patients. Am J Hosp Pharm 50: 1875-1884.
47. Nazareth I, Burton A, Shulman S, Smith P, Haines A, et al. (2001) A pharmacy discharge plan for hospitalized elderly patients: a randomized controlled trial. Age Ageing 30: 33-40.
48. Al-Rashed SA, Wright DJ, Roebuck N, Sunter W, Chrystyn H, (2002) The value of inpatient pharmaceutical counselling to elderly patients prior to discharge. Br J Clin Pharmacol 54: 657-664.